Imperva (IMPV) Tops Q4 EPS by 29c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts IMPV Hot Sheet
Join SI Premium – FREE
Imperva (NASDAQ: IMPV) reported Q4 Non-GAAP EPS of $0.32, $0.29 better than the analyst estimate of $0.03. Revenue for the quarter came in at $78.4 million versus the consensus estimate of $70.21 million.
GUIDANCE:
Imperva sees Q1 2017 Non-GAAP EPS of ($0.06)-($0.02) ex-items, versus the consensus of ($0.11). Imperva sees Q1 2017 revenue of $67-69 million, versus the consensus of $66.5 million.
Sees FY 2017 Non-GAAP EPS $0.31-0.34 ex items versus consensus of $0.14. Revenues of $316-$319 million versus consensus of $305 million
For earnings history and earnings-related data on Imperva (IMPV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Accenture shares fall on insider sales and analyst downgrade
- Pfizer's 25-valent pneumococcal vaccine shows Phase 2 results
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
